Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide for Physical Performance in Older Adults
NCT06465602Phase 2Recruiting
- Sponsor
- Universidad de Chile
- Start
- May 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in frailty syndrome and accidental falls comparing Nicotinamide with Placebo (2 arms). Primary endpoint: Short Physical Performance Battery at 4 weeks. Started May 2024; status: recruiting.
02
Drugs
nicotinamide
03
Conditions
frailty syndromeaccidental falls
Beyond the preview
Go deeper on NCT06465602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465602.